Vascular diseases (Paris, France)

Aspirin for primary prevention in patients with high lipoprotein(a): A promising therapeutic option while awaiting future therapies?

Pub Date : 2026-10-15 DOI: 10.1016/j.vasdi.2026.09.001 Francesca Vittone, Giuliana Autiero, Sara Angela Malerba, Elisabetta Grolla, Michele Dalla Vestra

Optimizing pharmacologic thromboprophylaxis in medical inpatients using sequential IMPROVE risk assessment models: Clinical, economic and environmental implications.

Pub Date : 2026-10-15 DOI: 10.1016/j.vasdi.2026.09.002 Théo Bourny, Salomé Bougerolle, Ygal Benhamou, Sébastien Miranda

Physical activity and cardiovascular risk factors in familial hypercholesterolemia: A scoping review.

Pub Date : 2026-09-10 DOI: 10.1016/j.vasdi.2026.08.002 Alyssa Dolwick, Kristen Heitman, Brooke Starkoff